Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease

Affiliations

¹ Department of Cardiology, Columbia University Medical Center/NY Presbyterian Hospital, New York, NY, USA.
² Department of Medicine, Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) - Université Laval, Canada.
³ Division of Cardiology, University of Washington School of Medicine, Seattle, WA, USA.

Editorial

Rebecca T Hahn et al. Eur Heart J. 2022.

. 2022 Aug 1;43(29):2767-2769.

doi: 10.1093/eurheartj/ehac229.

¹ Department of Cardiology, Columbia University Medical Center/NY Presbyterian Hospital, New York, NY, USA.
² Department of Medicine, Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) - Université Laval, Canada.
³ Division of Cardiology, University of Washington School of Medicine, Seattle, WA, USA.

Erratum in

Erratum to: Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
[No authors listed] [No authors listed] Eur Heart J. 2022 Oct 21;43(40):4160. doi: 10.1093/eurheartj/ehac373. Eur Heart J. 2022. PMID: 35781572 No abstract available.

No abstract available

Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
Tribouilloy C, Bohbot Y, Kubala M, Ruschitzka F, Popescu B, Wendler O, Laroche C, Bartha E, Ince H, Simkova I, Vahanian A, Iung B. Tribouilloy C, et al. Eur Heart J. 2022 Aug 1;43(29):2756-2766. doi: 10.1093/eurheartj/ehac209. Eur Heart J. 2022. PMID: 35511056
Erratum to: Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease.
[No authors listed] [No authors listed] Eur Heart J. 2022 Oct 21;43(40):4160. doi: 10.1093/eurheartj/ehac373. Eur Heart J. 2022. PMID: 35781572 No abstract available.